Clinova, a global consumer healthcare company developing ORS hydration tablets, has announced its strategic agreement with Muscat Pharmaceutical Trading, a trading company importing pharmaceuticals, medical devices, surgical disposables and FMCG goods.

The agreement gives Muscat Pharmaceutical Trading the rights to represent Clinova’s ORS hydration tablets in the UAE market.

John Honey, chief strategy officer of Clinova, said he sees many synergies between Clinova and Muscat Pharmaceutical Trading and looks forward to a highly successful partnership with the company.

"Clinova’s ORS hydration tablets are a ground-breaking, patented balanced formula of glucose, electrolytes and minerals which when added to water help maintain optimal hydration. The new agreement with Muscat Pharmaceutical Trading will not only allow us to expand our advocacy in the region, but also offer our customers a strong value proposition in a challenging healthcare environment," said Arsalan Karim, director of research and development of Clinova.

The ORS hydration tablets are available in all good pharmacies in the UAE including Boots, Life, Aster Pharmacy and Bin Sina. UAE sales of ORS hydration tablets are one of the highest in the world with 800,000 packs due to be sold in 2017, making it one of the most popular consumer healthcare products in the emirates.

 “Clinova’s ORS hydration tablet is a fascinating product. Since the tablets are non-carbonated, low in sugar and calories and suitable for all diets, we are delighted to be representing Clinova in the UAE. Together, we look forward to offering this ground-breaking Hydration Tablets to customers in the region,” said Nilay Shah of Muscat Pharmaceutical Trading. – TradeArabia News Service